Routine dematerialization compliance certificate for Sep 2026 quarter
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Everest Organics submitted a certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate was issued by Venture Capital and Corporate Investments, the company's Registrar and Share Transfer Agent, confirming that shares received for dematerialization were duly verified, cancelled, and updated in NSDL and CDSL records within 15 days. The filing is signed by Managing Director and CEO Sirisha Srikakarlapudi.
Routine procedural compliance filing. No material impact on shareholders or stock price.